We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Atherotech Diagnostics Lab Announces 2012 Sponsorship Grant to National Lipid Association
News

Atherotech Diagnostics Lab Announces 2012 Sponsorship Grant to National Lipid Association

Atherotech Diagnostics Lab Announces 2012 Sponsorship Grant to National Lipid Association
News

Atherotech Diagnostics Lab Announces 2012 Sponsorship Grant to National Lipid Association

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Atherotech Diagnostics Lab Announces 2012 Sponsorship Grant to National Lipid Association"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

"It's rewarding to see the value that Atherotech places on our mission of education and advancing the practice of clinical lipidology for the NLA and its members," said Christopher Seymour, Executive Director of the National Lipid Association. "The NLA greatly appreciates this generous grant in support of our educational programming and objectives."

Atherotech upholds the educational mission of the NLA and contributes to its goals of engaging members in clinical lipidology. Atherotech will partner with the NLA to offer advanced lipid testing and inflammatory markers seminars and support the organization's three scientific meetings:

-- Spring Clinical Lipid Update held March 9-11 in San Diego, Calif.
-- NLA Annual Scientific Sessions held May 31-June 3 in Scottsdale, Ariz.
-- Summer Clinical Update September 14-16 in Charlotte, N.C.

"Atherotech is committed to educating the physician community on advances in improved cardiovascular risk assessment and personalized treatment strategies to improve patient outcomes," said Atherotech CEO Michael Mullen. "We're proud to support the NLA in its mission."

Advertisement